- Fourth Quarter 2023 Net Investment Income per Share of $0.45; NAV per Share of $9.71 -
- Annual Debt Portfolio Yield of 16.6% -
- HRZN Ends Year with Committed Backlog of $218 Million -
- Declares.
Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors bought 1,885 put options on the company. This is an increase of 1,101% compared to the average volume of 157 put options. Evelo Biosciences Stock Performance Shares of EVLO opened at $0.05 on Friday. The […]
Horizon Technology: High Quality BDC But Overvalued (NASDAQ:HRZN) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
China Health Industries (OTCMKTS:CHHE) and Evelo Biosciences (NASDAQ:EVLO) Financial Analysis theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders bought 1,885 put options on the stock. This is an increase of 1,101% compared to the typical volume of 157 put options. Institutional Trading of Evelo Biosciences Institutional investors have recently added to or […]